價(jià)格 | 詢價(jià) |
包裝 | 1件 |
最小起訂量 | 1件 |
發(fā)貨地 | 北京 |
更新日期 | 2025-08-01 |
中文名稱:Revmab Bioscience Rabbit Monoclonal Antibody | 英文名稱:Revmab Bioscience Rabbit Monoclonal Antibody |
品牌: Revmab | 產(chǎn)品類別: 熱門產(chǎn)品 |
貨號(hào): 31-1062-00/31-1226-00 | 是否進(jìn)口: 是 |
產(chǎn)品規(guī)格: 25 ug; 100 ug |
維百奧現(xiàn)貨銷售Revmab Bioscience Rabbit Monoclonal Antibody
| 產(chǎn)品信息
品名:Revmab Bioscience Rabbit Monoclonal Antibody 現(xiàn)貨熱銷
品牌:Revmab Biosciences
貨號(hào):31-1062-00/31-1226-00
規(guī)格:25 ug; 100 ug
| 產(chǎn)品屬性
Product Name | Anti-Trimethyl-Histone H3 (Lys27) Rabbit Monoclonal Antibody | Anti-Trimethyl-Histone H3 (Lys4) Rabbit Monoclonal Antibody |
Catalog No. | 31-1062-00 | 31-1226-00 |
Clone Name | RM175 | RM340 |
Product Data Sheet |
|
|
Specificity | RM175 reacts to Histone H3 trimethylated at Lysine 27 (K27me3). No cross reactivity non-modified Lysine 27, monomethylated Lysine 27 (K27me1) or dimethylated Lysine 27 (K27me2), or other methylations in histone H3. | RM340 reacts to Histone H3 trimethylated at Lysine 4 (K4me3). No cross reactivity with monomethylated Lysine 4 (K4me1), dimethylated Lysine 4 (K4me3), or other methylations in histone H3. |
Immunogen | A trimethyl-peptide corresponding to trimethyl-Histone H3 (Lys27). | A trimethyl-peptide corresponding to Trimethyl-Histone H3 (Lys4). |
Application | Chromatin IP (ChIP);Western Blot (WB);Immunohistochemistry (IHC) ELISA;Multiplex | Chromatin IP (ChIP);ELISA;Multiplex |
Species Reactivity | Human;Vertebrates | Human;Vertebrates |
Purity | Protein A affinity purified from an animal origin–free culture supernatant | Protein A affinity purified from an animal origin–free culture supernatant |
成立日期 | 2014-03-04 (12年) | 注冊(cè)資本 | 300萬人民幣 |
員工人數(shù) | 10-50人 | 年?duì)I業(yè)額 | ¥ 1000萬-5000萬 |
主營(yíng)行業(yè) | 化學(xué)試劑 | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
碧云天生物技術(shù)有限公司
|
2025-08-02 | ||
¥5850 |
武漢艾美捷科技有限公司
|
2025-08-02 | ||
¥1640.00 |
VIP10年
|
北京索萊寶科技有限公司
|
2025-08-05 |